Stock RPHM RENEO PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Reneo Pharmaceuticals, Inc.

Equities

RPHM

US75974E1038

Market Closed - Nasdaq
Other stock markets
 21:30:01 03/05/2024 BST 		5-day change 1st Jan Change
1.74 USD +0.58% Intraday chart for Reneo Pharmaceuticals, Inc. +4.19% +8.75%
03-28 Reneo Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
03-25 North American Morning Briefing : Tech in Focus on -2- DJ

Evolution of the average Target Price on Reneo Pharmaceuticals, Inc.

Price target over the last 5 years

History of analyst recommendation changes

976c03eebbf0daf6f7a9b.tF4Sa9QcyeJGYjPO7uiJbkF3SRMZ69xQYaZi5IwocvI.3hRiL6xRjK8PJ3_7poOxDScuPV9KvOgIUd8khcBLGavtHF0y-WSGoxY7RA~172d31642530cade278697248ef749f1

Analyst Recommendations on Reneo Pharmaceuticals, Inc.

Ladenburg Thalmann Downgrades Reneo Pharmaceuticals to Neutral From Buy MT
HC Wainwright Downgrades Reneo Pharmaceuticals to Neutral From Buy, Cuts Price Target to $1.50 From $30 MT
Piper Sandler Downgrades Reneo Pharmaceuticals to Neutral From Overweight, Adjusts Price Target to $4 From $25 MT
Baird Downgrades Reneo Pharmaceuticals to Neutral From Outperform, Cuts Price Target to $3 From $28 MT
William Blair Starts Reneo Pharmaceuticals With Outperform Rating MT
BofA Securities Starts Reneo Pharmaceuticals at Buy With $23 Price Target MT
HC Wainwright Assumes Reneo Pharmaceuticals at Buy with $31 Price Target MT
Piper Sandler Adjusts Price Target on Reneo Pharmaceuticals to $18 From $45, Reiterates Overweight Rating MT
SVB Leerink Adjusts Reneo Pharmaceuticals' Price Target to $15 from $25, Keeps Outperform Rating MT
Baird Starts Reneo Pharmaceuticals at Outperform With $28 Price Target MT
HC Wainwright Starts Reneo Pharmaceuticals at Buy With $28 Price Target MT
Ladenburg Thalmann Starts Reneo Pharmaceuticals at Buy With $45 Price Target MT
RENEO PHARMACEUTICALS : Piper Sandler Starts Reneo Pharmaceuticals at Overweight With $45 Price Target MT
RENEO PHARMACEUTICALS : SVB Leerink Starts Reneo Pharmaceuticals at Outperform With $25 Price Target MT
RENEO PHARMACEUTICALS : Jefferies Starts Reneo Pharmaceuticals at Buy With $24 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
5
Last Close Price
1.74 USD
Average target price
1.9 USD
Spread / Average Target
+9.20%
High Price Target
3 USD
Spread / Highest target
+72.41%
Low Price Target
1.2 USD
Spread / Lowest Target
-31.03%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Reneo Pharmaceuticals, Inc.

Ladenburg Thalmann
HC Wainwright
Piper Sandler
Baird
William Blair & Co.
BofA Securities
SVB Leerink
Jefferies & Co.

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. RPHM Stock
  4. Consensus Reneo Pharmaceuticals, Inc.